Role of berberine in Alzheimer’s disease
Zhiyou Cai,1,* Chuanling Wang,1,* Wenming Yang2 1Department of Neurology, Renmin Hospital, Hubei University of Medicine, Shiyan Renmin Hospital, Shiyan, Hubei Province, 2Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui Province, People&...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-10-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Subjects: | |
| Online Access: | https://www.dovepress.com/role-of-berberine-in-alzheimerrsquos-disease-peer-reviewed-fulltext-article-NDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849433481426239488 |
|---|---|
| author | Cai Z Wang C Yang W |
| author_facet | Cai Z Wang C Yang W |
| author_sort | Cai Z |
| collection | DOAJ |
| description | Zhiyou Cai,1,* Chuanling Wang,1,* Wenming Yang2 1Department of Neurology, Renmin Hospital, Hubei University of Medicine, Shiyan Renmin Hospital, Shiyan, Hubei Province, 2Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui Province, People’s Republic of China *These authors contributed equally to this work Abstract: Berberine, an important protoberberine isoquinoline alkaloid, has several pharmacological activities, including antimicrobial, glucose- and cholesterol-lowering, antitumoral, and immunomodulatory properties. Substantial studies suggest that berberine may be beneficial to Alzheimer’s disease (AD) by limiting the pathogenesis of extracellular amyloid plaques and intracellular neurofibrillary tangles. Increasing evidence has indicated that berberine exerts a protective role in atherosclerosis related to lipid- and glucose-lowering properties, implicating that berberine has the potential to inhibit these risk factors for AD. This review also attempts to discuss the pharmacological basis through which berberine may retard oxidative stress and neuroinflammation to exhibit its protective role in AD. Accordingly, berberine might be considered a potential therapeutic approach to prevent or delay the process of AD. However, more detailed investigations along with a safety assessment of berberine are warranted to clarify the role of berberine in limiting these risk factors and AD-related pathologies. Keywords: berberine, amyloid, tau, oxidative stress, neuroinflammation, risk factors |
| format | Article |
| id | doaj-art-33a16c80e13141bb9abe83b920cbddca |
| institution | Kabale University |
| issn | 1178-2021 |
| language | English |
| publishDate | 2016-10-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Neuropsychiatric Disease and Treatment |
| spelling | doaj-art-33a16c80e13141bb9abe83b920cbddca2025-08-20T03:27:01ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212016-10-01Volume 12Issue 12509252029230Role of berberine in Alzheimer’s diseaseCai Z0Wang CYang WDepartment of NeurologyZhiyou Cai,1,* Chuanling Wang,1,* Wenming Yang2 1Department of Neurology, Renmin Hospital, Hubei University of Medicine, Shiyan Renmin Hospital, Shiyan, Hubei Province, 2Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui Province, People’s Republic of China *These authors contributed equally to this work Abstract: Berberine, an important protoberberine isoquinoline alkaloid, has several pharmacological activities, including antimicrobial, glucose- and cholesterol-lowering, antitumoral, and immunomodulatory properties. Substantial studies suggest that berberine may be beneficial to Alzheimer’s disease (AD) by limiting the pathogenesis of extracellular amyloid plaques and intracellular neurofibrillary tangles. Increasing evidence has indicated that berberine exerts a protective role in atherosclerosis related to lipid- and glucose-lowering properties, implicating that berberine has the potential to inhibit these risk factors for AD. This review also attempts to discuss the pharmacological basis through which berberine may retard oxidative stress and neuroinflammation to exhibit its protective role in AD. Accordingly, berberine might be considered a potential therapeutic approach to prevent or delay the process of AD. However, more detailed investigations along with a safety assessment of berberine are warranted to clarify the role of berberine in limiting these risk factors and AD-related pathologies. Keywords: berberine, amyloid, tau, oxidative stress, neuroinflammation, risk factorshttps://www.dovepress.com/role-of-berberine-in-alzheimerrsquos-disease-peer-reviewed-fulltext-article-NDTBerberineamyloidtauoxidative stressneuroinflammationrisk factors |
| spellingShingle | Cai Z Wang C Yang W Role of berberine in Alzheimer’s disease Neuropsychiatric Disease and Treatment Berberine amyloid tau oxidative stress neuroinflammation risk factors |
| title | Role of berberine in Alzheimer’s disease |
| title_full | Role of berberine in Alzheimer’s disease |
| title_fullStr | Role of berberine in Alzheimer’s disease |
| title_full_unstemmed | Role of berberine in Alzheimer’s disease |
| title_short | Role of berberine in Alzheimer’s disease |
| title_sort | role of berberine in alzheimer amp rsquo s disease |
| topic | Berberine amyloid tau oxidative stress neuroinflammation risk factors |
| url | https://www.dovepress.com/role-of-berberine-in-alzheimerrsquos-disease-peer-reviewed-fulltext-article-NDT |
| work_keys_str_mv | AT caiz roleofberberineinalzheimeramprsquosdisease AT wangc roleofberberineinalzheimeramprsquosdisease AT yangw roleofberberineinalzheimeramprsquosdisease |